NCT05199077View on ClinicalTrials.gov

A Study of GM-XANTHO in Pressure Ulcer Patients

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

September 1, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

April 30, 2029

Conditions

Pressure UlcerDiabetes Mellitus

Interventions

DRUG

GM-XANTHO

a topical applied ointment

Trial Locations (1)

100225

National Taiwan University Hospital, Taipei

All Listed Sponsors

collaborator

Virginia Contract Research Organization Co., Ltd.

OTHER

lead

Xantho Biotechnology Co., LTD

INDUSTRY